世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Global Intramuscular Drug Delivery Equipment Market Growth 2025-2031
The global Intramuscular Drug Delivery Equipment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. According... もっと見る
SummaryThe global Intramuscular Drug Delivery Equipment market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment. LP Information, Inc. (LPI) ' newest research report, the “Intramuscular Drug Delivery Equipment Industry Forecast” looks at past sales and reviews total world Intramuscular Drug Delivery Equipment sales in 2024, providing a comprehensive analysis by region and market sector of projected Intramuscular Drug Delivery Equipment sales for 2025 through 2031. With Intramuscular Drug Delivery Equipment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intramuscular Drug Delivery Equipment industry. This Insight Report provides a comprehensive analysis of the global Intramuscular Drug Delivery Equipment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intramuscular Drug Delivery Equipment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intramuscular Drug Delivery Equipment market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intramuscular Drug Delivery Equipment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intramuscular Drug Delivery Equipment. This report presents a comprehensive overview, market shares, and growth opportunities of Intramuscular Drug Delivery Equipment market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: Molecular Structures Polymers Gels Others Segmentation by Application: Infectious Disease Oncology Autoimmune Diseases This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration. Antares Pharma Eli Lily Galaxo HMD pharmaceuticals Inovio Pharmaceuticals Merck Novartis Pacira Pharmaceuticals Pfizer Pharmajet Teva Pharmaceutical Key Questions Addressed in this Report What is the 10-year outlook for the global Intramuscular Drug Delivery Equipment market? What factors are driving Intramuscular Drug Delivery Equipment market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Intramuscular Drug Delivery Equipment market opportunities vary by end market size? How does Intramuscular Drug Delivery Equipment break out by Type, by Application? Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Intramuscular Drug Delivery Equipment Annual Sales 2020-2031 2.1.2 World Current & Future Analysis for Intramuscular Drug Delivery Equipment by Geographic Region, 2020, 2024 & 2031 2.1.3 World Current & Future Analysis for Intramuscular Drug Delivery Equipment by Country/Region, 2020, 2024 & 2031 2.2 Intramuscular Drug Delivery Equipment Segment by Type 2.2.1 Molecular Structures 2.2.2 Polymers 2.2.3 Gels 2.2.4 Others 2.3 Intramuscular Drug Delivery Equipment Sales by Type 2.3.1 Global Intramuscular Drug Delivery Equipment Sales Market Share by Type (2020-2025) 2.3.2 Global Intramuscular Drug Delivery Equipment Revenue and Market Share by Type (2020-2025) 2.3.3 Global Intramuscular Drug Delivery Equipment Sale Price by Type (2020-2025) 2.4 Intramuscular Drug Delivery Equipment Segment by Application 2.4.1 Infectious Disease 2.4.2 Oncology 2.4.3 Autoimmune Diseases 2.5 Intramuscular Drug Delivery Equipment Sales by Application 2.5.1 Global Intramuscular Drug Delivery Equipment Sale Market Share by Application (2020-2025) 2.5.2 Global Intramuscular Drug Delivery Equipment Revenue and Market Share by Application (2020-2025) 2.5.3 Global Intramuscular Drug Delivery Equipment Sale Price by Application (2020-2025) 3 Global by Company 3.1 Global Intramuscular Drug Delivery Equipment Breakdown Data by Company 3.1.1 Global Intramuscular Drug Delivery Equipment Annual Sales by Company (2020-2025) 3.1.2 Global Intramuscular Drug Delivery Equipment Sales Market Share by Company (2020-2025) 3.2 Global Intramuscular Drug Delivery Equipment Annual Revenue by Company (2020-2025) 3.2.1 Global Intramuscular Drug Delivery Equipment Revenue by Company (2020-2025) 3.2.2 Global Intramuscular Drug Delivery Equipment Revenue Market Share by Company (2020-2025) 3.3 Global Intramuscular Drug Delivery Equipment Sale Price by Company 3.4 Key Manufacturers Intramuscular Drug Delivery Equipment Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Intramuscular Drug Delivery Equipment Product Location Distribution 3.4.2 Players Intramuscular Drug Delivery Equipment Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) 3.6 New Products and Potential Entrants 3.7 Market M&A Activity & Strategy 4 World Historic Review for Intramuscular Drug Delivery Equipment by Geographic Region 4.1 World Historic Intramuscular Drug Delivery Equipment Market Size by Geographic Region (2020-2025) 4.1.1 Global Intramuscular Drug Delivery Equipment Annual Sales by Geographic Region (2020-2025) 4.1.2 Global Intramuscular Drug Delivery Equipment Annual Revenue by Geographic Region (2020-2025) 4.2 World Historic Intramuscular Drug Delivery Equipment Market Size by Country/Region (2020-2025) 4.2.1 Global Intramuscular Drug Delivery Equipment Annual Sales by Country/Region (2020-2025) 4.2.2 Global Intramuscular Drug Delivery Equipment Annual Revenue by Country/Region (2020-2025) 4.3 Americas Intramuscular Drug Delivery Equipment Sales Growth 4.4 APAC Intramuscular Drug Delivery Equipment Sales Growth 4.5 Europe Intramuscular Drug Delivery Equipment Sales Growth 4.6 Middle East & Africa Intramuscular Drug Delivery Equipment Sales Growth 5 Americas 5.1 Americas Intramuscular Drug Delivery Equipment Sales by Country 5.1.1 Americas Intramuscular Drug Delivery Equipment Sales by Country (2020-2025) 5.1.2 Americas Intramuscular Drug Delivery Equipment Revenue by Country (2020-2025) 5.2 Americas Intramuscular Drug Delivery Equipment Sales by Type (2020-2025) 5.3 Americas Intramuscular Drug Delivery Equipment Sales by Application (2020-2025) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Intramuscular Drug Delivery Equipment Sales by Region 6.1.1 APAC Intramuscular Drug Delivery Equipment Sales by Region (2020-2025) 6.1.2 APAC Intramuscular Drug Delivery Equipment Revenue by Region (2020-2025) 6.2 APAC Intramuscular Drug Delivery Equipment Sales by Type (2020-2025) 6.3 APAC Intramuscular Drug Delivery Equipment Sales by Application (2020-2025) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Intramuscular Drug Delivery Equipment by Country 7.1.1 Europe Intramuscular Drug Delivery Equipment Sales by Country (2020-2025) 7.1.2 Europe Intramuscular Drug Delivery Equipment Revenue by Country (2020-2025) 7.2 Europe Intramuscular Drug Delivery Equipment Sales by Type (2020-2025) 7.3 Europe Intramuscular Drug Delivery Equipment Sales by Application (2020-2025) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Intramuscular Drug Delivery Equipment by Country 8.1.1 Middle East & Africa Intramuscular Drug Delivery Equipment Sales by Country (2020-2025) 8.1.2 Middle East & Africa Intramuscular Drug Delivery Equipment Revenue by Country (2020-2025) 8.2 Middle East & Africa Intramuscular Drug Delivery Equipment Sales by Type (2020-2025) 8.3 Middle East & Africa Intramuscular Drug Delivery Equipment Sales by Application (2020-2025) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Intramuscular Drug Delivery Equipment 10.3 Manufacturing Process Analysis of Intramuscular Drug Delivery Equipment 10.4 Industry Chain Structure of Intramuscular Drug Delivery Equipment 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Intramuscular Drug Delivery Equipment Distributors 11.3 Intramuscular Drug Delivery Equipment Customer 12 World Forecast Review for Intramuscular Drug Delivery Equipment by Geographic Region 12.1 Global Intramuscular Drug Delivery Equipment Market Size Forecast by Region 12.1.1 Global Intramuscular Drug Delivery Equipment Forecast by Region (2026-2031) 12.1.2 Global Intramuscular Drug Delivery Equipment Annual Revenue Forecast by Region (2026-2031) 12.2 Americas Forecast by Country (2026-2031) 12.3 APAC Forecast by Region (2026-2031) 12.4 Europe Forecast by Country (2026-2031) 12.5 Middle East & Africa Forecast by Country (2026-2031) 12.6 Global Intramuscular Drug Delivery Equipment Forecast by Type (2026-2031) 12.7 Global Intramuscular Drug Delivery Equipment Forecast by Application (2026-2031) 13 Key Players Analysis 13.1 Antares Pharma 13.1.1 Antares Pharma Company Information 13.1.2 Antares Pharma Intramuscular Drug Delivery Equipment Product Portfolios and Specifications 13.1.3 Antares Pharma Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2025) 13.1.4 Antares Pharma Main Business Overview 13.1.5 Antares Pharma Latest Developments 13.2 Eli Lily 13.2.1 Eli Lily Company Information 13.2.2 Eli Lily Intramuscular Drug Delivery Equipment Product Portfolios and Specifications 13.2.3 Eli Lily Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2025) 13.2.4 Eli Lily Main Business Overview 13.2.5 Eli Lily Latest Developments 13.3 Galaxo 13.3.1 Galaxo Company Information 13.3.2 Galaxo Intramuscular Drug Delivery Equipment Product Portfolios and Specifications 13.3.3 Galaxo Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2025) 13.3.4 Galaxo Main Business Overview 13.3.5 Galaxo Latest Developments 13.4 HMD pharmaceuticals 13.4.1 HMD pharmaceuticals Company Information 13.4.2 HMD pharmaceuticals Intramuscular Drug Delivery Equipment Product Portfolios and Specifications 13.4.3 HMD pharmaceuticals Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2025) 13.4.4 HMD pharmaceuticals Main Business Overview 13.4.5 HMD pharmaceuticals Latest Developments 13.5 Inovio Pharmaceuticals 13.5.1 Inovio Pharmaceuticals Company Information 13.5.2 Inovio Pharmaceuticals Intramuscular Drug Delivery Equipment Product Portfolios and Specifications 13.5.3 Inovio Pharmaceuticals Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2025) 13.5.4 Inovio Pharmaceuticals Main Business Overview 13.5.5 Inovio Pharmaceuticals Latest Developments 13.6 Merck 13.6.1 Merck Company Information 13.6.2 Merck Intramuscular Drug Delivery Equipment Product Portfolios and Specifications 13.6.3 Merck Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2025) 13.6.4 Merck Main Business Overview 13.6.5 Merck Latest Developments 13.7 Novartis 13.7.1 Novartis Company Information 13.7.2 Novartis Intramuscular Drug Delivery Equipment Product Portfolios and Specifications 13.7.3 Novartis Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2025) 13.7.4 Novartis Main Business Overview 13.7.5 Novartis Latest Developments 13.8 Pacira Pharmaceuticals 13.8.1 Pacira Pharmaceuticals Company Information 13.8.2 Pacira Pharmaceuticals Intramuscular Drug Delivery Equipment Product Portfolios and Specifications 13.8.3 Pacira Pharmaceuticals Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2025) 13.8.4 Pacira Pharmaceuticals Main Business Overview 13.8.5 Pacira Pharmaceuticals Latest Developments 13.9 Pfizer 13.9.1 Pfizer Company Information 13.9.2 Pfizer Intramuscular Drug Delivery Equipment Product Portfolios and Specifications 13.9.3 Pfizer Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2025) 13.9.4 Pfizer Main Business Overview 13.9.5 Pfizer Latest Developments 13.10 Pharmajet 13.10.1 Pharmajet Company Information 13.10.2 Pharmajet Intramuscular Drug Delivery Equipment Product Portfolios and Specifications 13.10.3 Pharmajet Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2025) 13.10.4 Pharmajet Main Business Overview 13.10.5 Pharmajet Latest Developments 13.11 Teva Pharmaceutical 13.11.1 Teva Pharmaceutical Company Information 13.11.2 Teva Pharmaceutical Intramuscular Drug Delivery Equipment Product Portfolios and Specifications 13.11.3 Teva Pharmaceutical Intramuscular Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2020-2025) 13.11.4 Teva Pharmaceutical Main Business Overview 13.11.5 Teva Pharmaceutical Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
LP Information社の医療分野での最新刊レポート
本レポートと同じKEY WORD（drug）の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
